Cytotoxic-antineoplastic derivatives of prenyl-1,2-naphthohydroquinone

Archiv der Pharmazie

Volumn 341, Issue 5, 2008, Pages 301-306

  Molinari, Aurora ^a   Oliva, Alfonso ^a   Ojeda, Claudia ^a   Miguel Del Corral, José M ^b   Castro, M Angeles ^b   Cuevas, Carmen ^c   Feliciano, Arturo San ^b  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE VALPARAÍSO   (Chile)

^b UNIVERSITY OF SALAMANCA   (Spain)

^c PHARMAMAR S A   (Spain)

Author keywords

Myrcene; 1,2 Benzoquinone; Antineoplastic cytotoxicity; Naphthohydroquinone

Indexed keywords

6(7) (3' ACETOXYPROPYL) 5,8 DIHYDRO 1,2 NAPHTHOHYDROQUINONE DIACETATE; 6(7) (3' BROMOPROPYL) 1,2 NAPHTHOHYDROQUINONE DIACETATE; 6(7) (3' BROMOPROPYL) 5,8 DIHYDRO 1,2 NAPHTHOHYDROQUINONE DIACETATE; 6(7) (3' HYDROXYPROPYL) 5,8 DIHYDRO 1,2 NAPHTHOHYDROQUINONE DIACETATE; 6(7) (3' OXOPROPYL) 5,8 DIHYDRO 1,2 NAPHTHOHYDROQUINONE DIACETATE; 6(7) (4' METHYLPENT 3' ENYL) 5,8 DIHYDRO 1,2 NAPHTHOHYDROQUINONE DIACETATE; 6(7) [(3',4' EPOXY 4' METHYL)PENTYL] 5,8 DIHYDRO 1,2 NAPHTHOHYDROQUINONE DIACETATE; 6(7) [2' (METHOXYCARBONYL)ETHYL] 5,8 DIHYDRO 1,2 NAPHTHOHYDROQUINONE DIACETATE; 6(7) [3' (4 TOSYLOXY)PROPYL] 1,2 NAPHTHOHYDROQUINONE DIACETATE; 6(7) [3' (4 TOSYLOXY)PROPYL] 5,8 DIHYDRO 1,2 NAPHTHOHYDROQUINONE DIACETATE; ANTINEOPLASTIC AGENT; BENZOQUINONE DERIVATIVE; DOXORUBICIN; HYDROQUINONE DERIVATIVE; MYRCENE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST ADENOCARCINOMA; CANCER CELL CULTURE; CANCER INHIBITION; CARCINOMA CELL; CELL STRAIN HT29; CHEMICAL MODIFICATION; COLON CARCINOMA; CONTROLLED STUDY; CYCLOADDITION; DIELS ALDER REACTION; DRUG CYTOTOXICITY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; LUNG CARCINOMA; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; SYNTHESIS; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; HUMANS; HYDROQUINONES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 46449121071     PISSN: 03656233     EISSN: 15214184     Source Type: Journal    
DOI: 10.1002/ardp.200700259     Document Type: Article

References (35)

1. P. J. O'Brien, Chem. Biol. Interact. 1991, 80, 1-41.
2. T. J. Monks, R. P. Hanzlik, G. M. Cohen, D. Ross, D. G. Graham, Toxicol. Appl. Pharmacol. 1992, 112, 2-16.
3. R. H. Thompson in Naturally Occurring Quinones IV; Recent Advances, Blackie Academic & Professional, London, UK, 1997.
4. th Ed., ACS, Washington, DC, 1995, Chapter 37, pp. 822-845.
5. B. N. Ravi, H. P. Perzanowsky, R. A. Ross, T. R. Ermaid, et al., Pure Appl. Chem. 1979, 51, 1893-1900.
6. P. Amade, L. Chevolot, H. P. Perzanowsky, P. Scheuer, Helv. Chim. Acta 1983, 66, 1672-1675.
7. M. L. Kondracki, Tetrahedron 1989, 45, 1995-2004.
8. M. T. Amman, P. J. Scheuer, Tetrahedron Lett. 1991, 32, 5271-5272.
9. M. T. Amman, P. J. Scheuer, J. Org. Chem. 1993, 58, 6565-6569.
10. A. F. Barrero, E. J. Alvarez-Manzaneda, R. Chauhboun, M. Cortés, V. Armstrong, Tetrahedron 1999, 55, 15181-15208.
11. M. E. Castro, M. González-Iriarte, A. F. Barrero, N. Salvador-Tormo, et al., Int. J. Cancer 2004, 110, 31-38.
12. Y. Xiong, K. Wang, Y. Pan, H. Sun, J. Tu, Bioorg. Med. Chem. Lett. 2006, 16, 786-789.
13. Y. Aoyagi, Y. Takahashi, Y. Satake, K. Takeya, et al., Bioorg. Med. Chem. 2006, 14, 5285-5291.
14. Z. D. Huang, Y. N. Chen, K. Menon, B. Teicher, J. Med. Chem. 1993, 36, 1797-1801.
15. N. Kongkathip, B. Kongkathip, P. Siripong, C. Sangma, et al., Bioorg. Med. Chem. 2003, 11, 3179-3191.
16. N. R. Sperandeo, M. C. Briñón, R. Brun, Farmaco 2004, 59, 431-435.
17. H. J. Lee, M. Suh, C. O. Lee, Bioorg. Med. Chem. 2003, 11, 1511-1519.
18. M. Gordaliza, J. M. Miguel del Corral, M. A. Castro, M. M. Mahiques, et al., Bioorg. Med. Chem. Lett. 1996, 6, 1859-1864.
19. J. M. Miguel del Corral, M. Gordaliza, M. A. Castro, M. M. Mahiques, et al., Bioorg. Med. Chem. 1998, 6, 31-41.
20. A. Molinari, A. Oliva, N. Aguilera, J. M. Miguel del Corral, et al., Bioorg. Med. Chem. 2000, 8, 1027-1032.
21. A. Molinari, A. Oliva, P. Reinoso, J. M. Miguel del Corral, et al., Eur. J. Med. Chem. 2002, 37, 177-182.
22. A. Molinari, A. Oliva, J. M. Miguel del Corral, M. A. Castro, et al., Farmaco 2004, 59, 651-656.
23. A. Molinari, A. Oliva, C. Ojeda, J. Escobar, et al., Bioorg. Med. Chem. 2005, 13, 3841-3846.
24. J. M. Miguel del Corral, M. Gordaliza, M. A. Castro, M. M. Mahiques, et al., J. Med. Chem. 2001, 44, 1257-1267.
25. A. Molinari, A. Oliva, C. Ojeda, J. M. Miguel del Corral, et al., Bioorg. Med. Chem. 2005, 13, 6645-6650.
26. E. Adler, I. Falkehag, B. Smith, Acta Chem. Scand. 1962, 16, 529-540.
27. M. Daumas, Y. Vo-Quang, L. Vo-Quang, F. Le Goffic, Synthesis 1989, 64-65.
28. B. T. Cho, S. K. Kang, Tetrahedron Lett. 2005, 61, 5725-5734.
29. F. E. Ziegler, S. I. Klein, U. K. Pati, T. F. Wang, J. Am. Chem. Soc. 1985, 107, 2730-2737.
30. D. E. Graves, L. M. Velea, Curr. Org. Chem. 2000, 4, 915-929.
31. M. F. Brana, M. Cacho, B. Gradillas, B. De Pacual-Teresa, A. Ramos, Curr. Pharm. Des. 2001, 7, 1745-1780.
32. H. L. Hurley, Nat. Rev. Cancer 2002, 2, 188-200.
33. J. H. Tan, Q. X. Zhang, Z. S. Huang, Y. Chen, et al., Eur. J. Med. Chem. 2006, 41, 1041-1047.
34. P. Skenan, R. Storeng, D. Scudiero, A. Monks, et al., J. Natl. Cancer Inst. 1990, 82, 1107-1112.
35. G. T. Faircloth, D. Stewart, J. J. J. Clement, J. Tissue Cult. Methods 1998, 11, 201-205.